<DOC>
	<DOCNO>NCT00461955</DOCNO>
	<brief_summary>Hematopoietic reconstitution define neutrophil number &gt; 500/mm3 day 7 injection ex vivo amplify graft platelet number &gt; 20000/mm3 , day 15 injection ex vivo amplify graft , without transfusion .</brief_summary>
	<brief_title>Injection ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation</brief_title>
	<detailed_description>To check injection autologous peripheral blood stem cell CD34 ( + ) `` amplified ex vivo presence SCF , G-CSF TPO HP01 Maco pharma medium culture . `` : Allows obtain hematopoietic reconstitution : 1 . Rapid : 7 day less injection , regard neutrophil 15 day less regard platelet 2 . Complete : number neutrophils platelet respectively high 500/mm3 20000/mm3 within time mention 3 . Stable : secondary neutropenia thrombocytopenia year follow injection , absence recurence myeloma .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Patient 18 65 year age Diagnosis Multiple Myeloma , require treatment , include high dose Melphalan whith autologous peripheral blood stem cell transplantation Performance status : &lt; 2 ( Karnofsky &gt; 70 % ) Anticipated survival &gt; 3 month Collection minimum 10x106 cell ( CD34+ ) /Kg autologous GCSF mobilise peripheral blood stem cell 2 3 pheresis . Signed date informed consent Multiple Myeloma require treatment Another cancer 5 year precede diagnosis evolutive psychiatric affection Positive serology HIV , hepatitis C hepatitis B Hepato cellular insufficiency Severe renal insufficiency define creatine clearance &lt; 30 ml/mn Women pregnant nursing , effective absence contraception Antecedent serious cardiac disease last 6 month . Allergy known product derive Escherichia Coli</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Symptomatic Multiple Myeloma</keyword>
	<keyword>first line treatment</keyword>
	<keyword>first autologous Stem Cell Transplantation</keyword>
	<keyword>ex vivo amplify autologous peripheral blood stem cell</keyword>
</DOC>